Ontology highlight
ABSTRACT: Background
Pancreatic ductal adenocarcinoma (PDAC) often presents with liver or peritoneal metastases at diagnosis. Despite similar treatment approaches, patient outcomes vary between these metastatic sites. To improve targeted therapies for metastatic PDAC, a comprehensive analysis of the genetic profiles and evolutionary patterns at these distinct metastatic locations is essential.Methods
We performed whole exome sequencing on 44 tissue samples from 27 PDAC patients, including primary tumours and matched liver or peritoneal metastases. We analysed somatic mutation profiles, signatures, and affected pathways for each group, and examined clonal evolution using subclonal architectures and phylogenetic trees.Results
KRAS mutations remained the predominant drive
SUBMITTER: Yao G
PROVIDER: S-EPMC11336646 | biostudies-literature | 2024 Aug
REPOSITORIES: biostudies-literature